Article
A Sequence-Based Update on Amino Acid Substitutions in Influenza Polymerase Acidic Protein in Europe That Alter Baloxavir Susceptibility From 2009 to 2025.
Influenza and other respiratory viruses - 1 Jul 2026
Martín-Toribio Alejandro, Inchausti-Moya Inés, Toquero-Asensio Marina, García-Díaz Sonia, Sanchez-Martinez Javier, Rodriguez-Crespo Carla, Galindo-Carretero Silvia, Iglesia-Aparicio Raquel, Lopez-Gonzalo Celia, Antón-Contreras Ana, Rojo-Rello Silvia, Dominguez-Gil Marta, Hernández Marta, Eiros Jose M, Nistal-Villan Estanislao, Sanz-Muñoz Iván
Abstract excerpt
BACKGROUND: Influenza causes 650,000 deaths, 3-5 million hospitalizations, and 1 billion cases worldwide each year. There is a limited repertoire of antivirals available to tackle this burden, highlighting the risk of developing resistance to current drugs. An effort to develop new influenza antivirals has been made, leading to the approval of baloxavir. Some mutations leading to reduced susceptibility to...
Topics
Join the communities discussing this publication.
